<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"  xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>ICAAC 2010 Newsroom</title>
        <description>ICAAC 2010 Newsroom</description>
        <link>http://www.thebody.com/index/confs/icaac2010/newsroom.html</link>
        <lastBuildDate>Wed, 01 May 2019 18:38:49 GMT</lastBuildDate>
        <generator>FeedCreator 1.8.0-dev (info@mypapit.net)</generator>
        <atom:link href="http://www.thebody.com/index/confs/icaac2010/newsroom.rss" rel="self" type="application/rss+xml" />
        <item>
            <title>Once-Daily &amp;quot;Extended&amp;quot; Formulation of Nevirapine Holds Up Well in 48-Week ...</title>
            <link>http://www.thebody.comhttp://www.thebodypro.com/content/art58455.html</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.com/content/art58455.html</guid>
        </item>
        <item>
            <title>&quot;Quad&quot; Pill Continues to Impress in Week-48 Results; Cobicistat Moves Forward in ...</title>
            <link>http://www.thebody.comhttp://www.thebodypro.com/content/art58436.html</link>
            <description></description>
            <pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.com/content/art58436.html</guid>
        </item>
        <item>
            <title>A Slice of Atazanavir, but Hold the Ritonavir: Switch to Unboosted Dose Still Effective After ...</title>
            <link>http://www.thebody.com/content/art58418.html</link>
            <description></description>
            <pubDate>Sun, 12 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.com/content/art58418.html</guid>
        </item>
        <item>
            <title>Even Among Long-Term HIV Nonprogressors, Some Signs of Heightened Cardiovascular Risk Exist, U. ...</title>
            <link>http://www.thebody.comhttp://www.thebodypro.com/content/art58417.html</link>
            <description></description>
            <pubDate>Sun, 12 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.com/content/art58417.html</guid>
        </item>
        <item>
            <title>Study Closes Vicriviroc Story</title>
            <link>http://www.thebody.comhttp://www.medpagetoday.com/HIVAIDS/HIVAIDS/22193</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.medpagetoday.com/HIVAIDS/HIVAIDS/22193</guid>
        </item>
        <item>
            <title>Switch to HIV Combo Pill May Improve Lipids</title>
            <link>http://www.thebody.comhttp://www.medpagetoday.com/HIVAIDS/HIVAIDS/22199</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.medpagetoday.com/HIVAIDS/HIVAIDS/22199</guid>
        </item>
        <item>
            <title>Insulin Resistance Correlates With HCV Load and SVR in HCV/HIV-Coinfected</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_31.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_31.htm</guid>
        </item>
        <item>
            <title>GSK New NNRTI Selects No Resistance Mutations in 7 Days of Monotherapy</title>
            <link>http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_30.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_30.htm</guid>
        </item>
        <item>
            <title>High Rates of Bone Loss and Progression With HIV in Longitudinal Study</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_19.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_19.htm</guid>
        </item>
        <item>
            <title>Top Integrase Polymorphisms Do Not Confer Resistance to S/GSK1349572 or Raltegravir</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_18.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_18.htm</guid>
        </item>
        <item>
            <title>Raltegravir Re-Use Response After Failure Depends on Mutation Pattern</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_17.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_17.htm</guid>
        </item>
        <item>
            <title>Long-Term Outcomes Good After Coreceptor Switch in Maraviroc Failure</title>
            <link>http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_16.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_16.htm</guid>
        </item>
        <item>
            <title>Longer Antiretroviral Therapy Favors Return to Normal HDL-C</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_15.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_15.htm</guid>
        </item>
        <item>
            <title>Novel Mutations and Shifting Susceptibility to Darunavir and Tipranavir</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_14.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_14.htm</guid>
        </item>
        <item>
            <title>TMC-278 Phase 3 ECHO/THRIVE Studies Resistance Profile Rilpivirine</title>
            <link>http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_22.htm</link>
            <description></description>
            <pubDate>Wed, 15 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_22.htm</guid>
        </item>
        <item>
            <title>People With X4 Virus Who Failed Selzentry Have Good Long-Term Results</title>
            <link>http://www.thebody.comhttp://aidsmeds.com/articles/hiv_maraviroc_selzentry_1667_19100.shtml</link>
            <description></description>
            <pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://aidsmeds.com/articles/hiv_maraviroc_selzentry_1667_19100.shtml</guid>
        </item>
        <item>
            <title>IL28B Gene Variation Associated With Lipid Levels in People With HIV/HCV Coinfection</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://www.hivandhepatitis.com/2010_conference/icaac/docs/0914_d.html</link>
            <description></description>
            <pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://www.hivandhepatitis.com/2010_conference/icaac/docs/0914_d.html</guid>
        </item>
        <item>
            <title>New NRTI Festinavir Exhibits Good Anti-HIV Activity and Safety in Phase 1b/2a Study</title>
            <link>http://www.thebody.comhttp://www.hivandhepatitis.com/2010_conference/icaac/docs/0914_c.html</link>
            <description></description>
            <pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.hivandhepatitis.com/2010_conference/icaac/docs/0914_c.html</guid>
        </item>
        <item>
            <title>Two Doses of Hep A Vaccine in HIV+ Men Equivalent to One Dose in HIV- Men</title>
            <link>http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_08.htm</link>
            <description></description>
            <pubDate>Tue, 14 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_08.htm</guid>
        </item>
        <item>
            <title>One Third on First-Line Antiretrovirals Have Clinically Significant Drug Interactions</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_03.htm</link>
            <description></description>
            <pubDate>Mon, 13 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_03.htm</guid>
        </item>
        <item>
            <title>ECG Abnormalities With PIs Versus NNRTIs in SMART Trial</title>
            <link>http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_04.htm</link>
            <description></description>
            <pubDate>Mon, 13 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.thebodypro.comhttp://natap.org/2010/ICAAC/ICAAC_04.htm</guid>
        </item>
        <item>
            <title>Maintenance With Raltegravir/Atazanavir Usually Effective for 48 Weeks (Low Troughs, a Few ...</title>
            <link>http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_02.htm</link>
            <description></description>
            <pubDate>Mon, 13 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_02.htm</guid>
        </item>
        <item>
            <title>Staph Rate Falling in HIV+ Danes, But Still High vs. General Population</title>
            <link>http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_01.htm</link>
            <description></description>
            <pubDate>Mon, 13 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://natap.org/2010/ICAAC/ICAAC_01.htm</guid>
        </item>
        <item>
            <title>HIV Patients at Risk for Low Vitamin D</title>
            <link>http://www.thebody.comhttp://www.medpagetoday.com/MeetingCoverage/ICAAC/22132</link>
            <description></description>
            <pubDate>Sun, 12 Sep 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.thebody.comhttp://www.medpagetoday.com/MeetingCoverage/ICAAC/22132</guid>
        </item>
    </channel>
</rss>
